Table 3.

Dose-intensity

		All patients		Young-elderly patients
		DI/cycle mg/m2(or Kg)/w		DI/cycle mg/m2(or Kg)/w
	Projected DI mg/m2(o Kg)/w	Median (Range)	Received DI (%)	Median (Range)	Received DI (%)
5-FU	1800	1487	82,6	1420	80
		(480-1800)		(480-1800)
CPT-11	80	66.7	83	61	76
		(25-80)		(25-80)
l-OHP	40	32	80	31.5	79
		(8-40)		(8-40)
BEV	2.5	2.1	84	2	80
		(1-2.5)		(1-2.5)

Abbreviation: DI, dose-intensity; 5-FU, 5-Fluorouracil; CPT-11, Irinotecan; l-OHP, Oxaliplatin; BEV, Bevacizumab.